The Drug Enforcement Agency (DEA) recently released guidance on the training requirements for the treatment and management of patients with opioid or other substance use disorders. Section 1263 of the Consolidated Appropriations Act of 2023, known as the Medication Access and Training Expansion (MATE) Act, requires new or renewing DEA registrants, as of June 27, 2023, to have completed a total of at least 8 hours of training on opioid or other substance use disorders. The requirements are outlined here.
The Substance Abuse and Mental Health Services Administration (SAMHSA) has released recommendations for curricular elements in substance use disorders training, which can be found here.
Please contact firstname.lastname@example.org with any questions.